解读药品价格登记系统：赋予中国创新药国际市场“新身份”

Core Viewpoint - The launch of the China Drug Price Registration System (China Drug Registration) is seen as a significant step to support the internationalization of Chinese innovative drugs and attract high-quality foreign drugs into the Chinese market [1][2]. Group 1: System Overview - The China Drug Registration system provides authoritative, standardized, and transparent market price registration services for enterprises, helping to establish a global and diversified drug pricing system [1]. - Prior to the system's launch, China's drug pricing was primarily based on provincial medical procurement platform prices, which did not reflect the true value of original innovative drug research and development [1][2]. Group 2: Benefits for Enterprises - With the new system, enterprises can independently register drug prices for various channels outside the medical insurance market, creating a globally accessible "registered price" [1][2]. - The system allows drug market authorization holders to obtain multilingual price query certificates, serving as valid proof of drug price registration [2]. Group 3: Impact on Innovation and Competition - The launch of the system is expected to enhance the enthusiasm of pharmaceutical companies for developing innovative drugs, making international market entry a necessity for many [3]. - The system also facilitates foreign high-quality drugs entering the Chinese market, promoting positive interaction between domestic and international markets [3].